A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

Clinical trial NCT05483439 · UNKNOWN

Trial details

NCT number: NCT05483439
Sponsor: Shengjing Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II-III Breast Cancer

Start date: 2021-10-20
Primary completion: 2023-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.